Pharmacokinetics of l-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
ConclusionThis is the first PK study in neonates presenting data that can be used to inform dosing strategies in future randomized controlled trials evaluating enterall-citrulline as a potential treatment to reduce PH associated with BPD in premature neonates.RegistrationClinical trials.gov Identifier: NCT03542812.
Source: Pediatric Drugs - Category: Pediatrics Source Type: research
More News: Bronchopulmonary Dysplasia | Children | Hypertension | Pediatrics | Pulmonary Hypertension | Study